In a recent development, the U.S. Food and Drug Administration (FDA) has announced an extension... (3 revisions)
In a recent development, the Medical Imaging Drugs Advisory Committee (MIDAC) of the U.S Food... (3 revisions)
In a study conducted by the U.S. Food and Drug Administration (FDA), it was found that most... (3 revisions)
The North American Renderers Association (NARA) is urging the US Environmental Protection Agency... (4 revisions)
In a recent article by Emma Rumney on Investing.com, it is reported that nicotine alternatives... (5 revisions)
Consumer Reports, a renowned consumer watchdog, has recently identified high levels of lead and... (8 revisions)
Daré Bioscience, Inc. (NASDAQ:DARE) reported its Q4 2023 earnings, surpassing expectations with... (11 revisions)
In recent years, the United States has become increasingly reliant on Chinese pharmaceuticals,... (12 revisions)
Amylyx Pharmaceuticals' ALS drug, Relyvrio, has failed in a Phase III trial, showing no efficacy... (12 revisions)
A new antibiotic called ceftobiprole, developed by Basilea Pharmaceutica, has been approved by... (13 revisions)
A recent decision by the Food and Drug Administration (FDA) has denied approval for MDMA therapy... (15 revisions)
In a significant development for both technology and healthcare, Apple has received FDA approval... (15 revisions)
On December 2, 2024, the U.S. Supreme Court heard arguments concerning a legal challenge from... (16 revisions)
The U.S. Food and Drug Administration (FDA) has recently made several significant approvals in... (17 revisions)
Novavax, a pharmaceutical company, is awaiting a decision from the US Food and Drug... (20 revisions)
In a significant development for U.S. healthcare, President-elect Donald Trump has nominated... (31 revisions)
In June 2024, the U.S. Supreme Court made a landmark decision to overrule the Chevron deference,... (34 revisions)
The rapid expansion of artificial intelligence (AI) applications is reshaping the energy... (66 revisions)